Perspectives on neuroblastoma

Pediatric Surgery International

Volumn 18, Issue 5-6, 2002, Pages 299-305

  Carachi, R ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; CARBOPLATIN; CATECHOLAMINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKINE; DNA; DOXORUBICIN; ETOPOSIDE; HOMOVANILLIC ACID; IODINE; RETINOIC ACID; VANILMANDELIC ACID; VINCRISTINE; MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN;

ADRENAL MEDULLA; ADRENAL TUMOR; ADRENERGIC SYSTEM; ANTIANGIOGENIC ACTIVITY; ASPIRATION BIOPSY; ATAXIA; BIOLOGY; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CALCIFICATION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CATECHOLAMINE METABOLISM; CATECHOLAMINE RELEASE; CELL MIGRATION; CHROMOSOME 1P; CHROMOSOME DELETION; COMPUTER ASSISTED TOMOGRAPHY; DNA CONTENT; ENVIRONMENTAL FACTOR; EYE; GANGLIONEUROMA; GENE AMPLIFICATION; GENE THERAPY; HEREDITY; HIRSCHSPRUNG DISEASE; HUMAN; HYPOVENTILATION; IMAGING; INCIDENTAL FINDING; LIVER METASTASIS; MOLECULAR BIOLOGY; MORTALITY; MYOCLONUS; NEURAL CREST; NEUROBLASTOMA; NEUROBLASTOMA CELL; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; ONCOGENE C MYB; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCHWANN CELL; SCINTIGRAPHY; SPINE TUMOR; SUPPRESSOR GENE; SYMPATHETIC GANGLION; SYMPATHETIC TRUNK; TUMOR; TUMOR BIOPSY; ULTRASOUND; URINE; WHOLE BODY RADIATION; GENETICS; NEEDLE BIOPSY; PATHOLOGY;

BIOPSY, NEEDLE; BONE MARROW TRANSPLANTATION; HUMANS; MOLECULAR BIOLOGY; NEOPLASM STAGING; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS;

EID: 0036730983     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-002-0793-4     Document Type: Review

References (53)

1. Virchow R (1864-1865) Hyperplasie der Zirbel und der Nebennieren. In Die Krankhaften Geschwulste. Hirschwald, Berlin, p 65
2. Wright JH (1910) Neurocytoma or neuroblastoma, a kind of tumor not generally recognized. J Exp Med 12: 556-561
3. Pepper WA (1901) A study of congenital sarcoma of the liver and suprarenal. Am J Med Sci 121: 287-299
4. Hutchinson R (1907) Suprarenal sarcoma in children with metastases to skull. Quart J Med 1: 33-38
5. Lehman EP (1917) Neuroblastoma. J Med Res 36: 309-326
6. Cushing H, Wolback BB (1927) Transformation of a malignant paravertebral sympathicoblastoma into a benign ganglioeuroma. Am J Pathol 3: 203-215
7. Gross RE, Farber S, Martin LW (1959) Neuroblastoma sympatheticum - a study and report of 217 cases. Pediatrics 23: 1179-1191
8. Farber S, Toch R (1951) Chemotherapy of disseminated neuroblastoma in children. Am J Dis Child 2: 239
9. Thurman WG, Ferbach DJ, Sullivan MP (1964) Cyclophosphamide therapy in childhood neuroblastoma. N Eng J Med 270: 1336-1340
10. Kramer S, Ward E, Meadows AT, et al (1987) Medical and drug risk factors associated with neuroblastoma: a case-control study. J Natl Cancer Inst 78: 797-804
11. Wilkins JR 3d, Hundley VD (1990) Paternal occupational exposure to electromagnetic fields and neuroblastoma in offspring. Am J Epidemiol 131: 995-1008
12. Dodge HJ, Benner MC (1945) Neuroblastoma of the adrenal medulla in siblings. Rocky Mt Med 42: 35-38
13. Brodeur GM, Sawada T, Tsuchida Y, Voute PA (eds) (2000) Neuroblastoma. Elsevier, Amsterdam, pp 125-135
14. Beckwith J, Perrin E (1963) In situ neuroblastomas: a contribution to the natural history of neural crest tumors. Am J Pathol 43: 1089-1104
15. Mason GA, Hart-Mercer J, Miller EJ, et al (1957) Adrenaline-secreting neuroblastoma in an infant. Lancet 2: 322-325
16. LaBrosse EH, Com-Nougue C, Zucker JM, et al (1980) Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors. Cancer Res 40: 1995-2001
17. Sawada T (1992) Past and future of neuroblastoma screening in Japan. Am J Pediatr Hematol Oncol 14: 320-326
18. Knudson AG Jr, Meadows AT (1980) Regression of neuroblastoma IV-S: a genetic hypothesis. N Engl J Med 302: 1254-1256
19. Brodeur GM, Fong CT (1989) Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet 41: 153-174
20. Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent JM (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305: 245-248
21. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224: 1121-1124
22. Brodeur GM, Seeger RC, Barret A, et al (1988) International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. J Clin Oncol 6: 1874-1881
23. Combaret V, Lasset C, Frappaz D, et al (1995) Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factors. Eur J Cancer 31A: 545-549
24. Helman LJ, Gazdar AF, Park J-G, et al (1988) Chromogranin A expression in normal and malignant human tissues. J Clin Invest 82: 686-690
25. Selig RA, Madafiglio J, Haber M, et al (1993) Ferritin production and desferrioxamine cytotoxicity in human neuroblastoma cell lines. Anticancer Res 13: 721-725
26. Quinn JJ, Altman AJ, Frantz CN (1980) Serum lactic dehydrogenase, an indicator of tumor activity in neuroblastoma. J Pediatr 97: 89-91
27. Berthold F, Engelhardt-Fahrner U, Schneider A, et al (1991) Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma. In Vivo 5: 245-247
28. Hiyama E, Hiyama K, Yokoyama T, et al (1995) Telomerase activity in human neuroblastoma. Proc Annu Meet Am Assoc Cancer Res 36: A3301
29. Evans AE, D'Angio GJ, Randolph J (1971) A proposed staging for children with neuroblastoma. Cancer 27: 374-378
30. Hayes FA, Green A, Hustu O, et al (1983) Surgicopathologic staging of neuroblastoma prognostic significance of regional lymph node metastases. J Pediatr 102: 59-62
31. Hayes FA, Smith EI (1989) Neuroblastoma. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. Lippincott, Philadelphia, p 614
32. Brodeur GM, Seeger RC, Barrett A, et al (1988) International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 6: 1874-1881
33. Brodeur GM, Prichard J, Berthold F, et al (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11: 1466-1477
34. Shimada H, Chatten J, Newton WA, et al (1984) Histopathologic prognostic factors in neuroblastic tumors: definition of sub-types of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73: 405-416
35. Joshi VV, Cantor AB, Altshuler G, et al (1992) Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. Cancer 69: 2197-2211
36. Joshi VV, Rao PV, Cantor AB, et al (1996) Modified histologic grading of neuroblastomas by replacement of mitotic rate with mitosis karyorrhexis index. A clinicopathologic study of 223 cases from the Pediatric Oncology Group. Cancer 77: 1582-1588
37. Meitar D, Crawford SE, Rademaker AW, Cohn SL (1996) Tumor angiogenesis correlates with metastatic disease, N-myc amplication, and poor outcome in human neuroblastoma. J Clin Oncol 14: 405-414
38. Weinblatt ME, Heisel MA, Siegel SE (1983) Hypertension in children with neurogenic tumors. Pediatrics 71: 947-951
39. Murthi GVS, Azmy A, Carachi R, Goel K (2001) Musculoskeletal manifestations of neuroblastoma at diagnosis. Med Pediatr Oncol 36: 671-672
40. Shapiro B, Shulkin BL, Hutchinson RJ, Bass JC, Gross MD, Sisson JC (1994) Location of neuroblastoma in the opsoclonus-myoclonus syndrome. J Nucl Biol Med 38: 545-555
41. Scheibel E, Rechnitzer C, Fahrenkrug J, Hertz H (1982) Vasoactive intestinal polypeptide (VIP) in children with neural crest tumors. Acta Paediatr Scand 71: 721-725
42. Hoefnagel CA, de Kraker J (1998) Childhood neoplasia. In: Murray IPC, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment, 2nd ed. Churchill Livingstone, London, pp 1001-1014
43. Smith MB, Katz R, Black CT, et al (1993) A rational approach to the use of fine needle aspiration biopsy in the evaluation of primary and recurrent neoplasms in children. J Pediatr Surg 28: 1245-1247
44. Ozkaynak MF, Seeger RC, Krailo M, Sondel P, Matthay K, Reamen G (1998) Phase 1 study of chimeric human/murine anti-GD2 monoclonal antibody (ch14, 18) with GM-CSF in children with neuroblastoma immediately post hematopoietic stem cell transplantation (HSCT): a Children's Cancer Group study. Proc Am Soc Clin Oncol 17: 532a
45. Stram DO, Matthay KK, O'Leary MC, et al (1995) Autologous bone marrow transplantation vs continued chemotherapy for stage IV neuroblastoma: a nonrandomized Childrens Cancer Group study. Proc Annu Meet Am Soc Clin Oncol 14: A1425
46. Peschel RE, Chen M, Seashore J (1991) The treatment of massive hepatomegaly in stage IV-S neuroblastoma. Int J Radiat Oncol Biol Phys 7: 549-553
47. Leavey PJ, Odom LF, Poole M, et al (1997) Intraoperative radiation therapy in pediatric neuroblastoma. Med Pediatr Oncol 28: (in press)
48. 131I metaiodobenzylguanidine and surgical resection of advanced neuroblastoma. Eur J Pediatr Surg 6: 155-158
49. Black CT, Hase GM, Azizkhan RG, et al (1996) Opitimal timing of primary tumor resection in high risk neuroblastoma. Med Pediatr Oncol 27: 220
50. Tsuchida Y, La Quaglia MP (2000) Surgery for neuroblastoma. In: Brodeur GM, Sawada T, Tsuchida Y, Voute PA (eds) Neuroblastoma. Elsevier, Amsterdam, pp 497-514
51. Fairchild RS, Kyner JL, Hermreck A, Schimke RN (1979) Neuroblastoma, pheochromocytoma and renal cell carcinoma. Occurrence in a single patient. JAMA 242: 2210-2211
52. Hunger SP, Sklar J, Link MP (1992) Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature. J Clin Oncol 10: 156-163
53. Ben-Arush MW, Doron Y, Braun J, et al (1990) Brain tumor as a second malignant neoplasm following neuroblastoma stage IVS. Med Pediatr Oncol 18: 240-245